Patents by Inventor William Stephen Faraci

William Stephen Faraci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS
    Publication number: 20200246404
    Abstract: The invention provides for compositions comprising one or more or at least two active ingredient(s), e.g., a cannabinoid, cannabinoid extract, terpene, or terpene extract. The invention includes cannabinoid formulations, including self-emulsifying formulations and micellar dispersions, as well as methods of making and using the same. Some formulations comprise a cannabinoid and surfactant. The formulations have improved dissolution, stability, absorption and/or oral bioavailability. Some of the formulations are rapid dispersing formulations.
    Type: Application
    Filed: February 13, 2020
    Publication date: August 6, 2020
    Inventors: Tuna Yucel, Scott S. Finnance, Stephen E. Zale, Nicholas J. Boylan, William Stephen Faraci
  • FORMULATIONS
    Publication number: 20200037638
    Abstract: The invention provides for cannabinoid formulations, including self-emulsifying formulations and micellar dispersions, as well as methods of making and using the same. The formulations comprise a cannabinoid and surfactant. The formulations have improved dissolution, stability, and pharmacokinetics, including absorption and/or oral bioavailability. The invention also provides for formulations comprising at least one active ingredient, including self-emulsifying formulations and micellar dispersions, as well as methods of making and using the same. The formulations comprise a least one active ingredient and surfactant.
    Type: Application
    Filed: August 12, 2019
    Publication date: February 6, 2020
    Inventors: William Stephen Faraci, Stephen E. Zale, Abhimanyu Paraskar, Tuna Yucel, Nicholas J. Boylan
  • Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
    Patent number: 6448265
    Abstract: The pyrazoles and pyrazolopyrimidines of the formula wherein R1, R2, R3, R4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.
    Type: Grant
    Filed: August 19, 1999
    Date of Patent: September 10, 2002
    Assignee: Pfizer, Inc.
    Inventors: William Stephen Faraci, Willard McKowan Welch, Jr.
  • Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
    Patent number: 6441018
    Abstract: The pyrazoles and pyrazolopyrimidines of the formula wherein R1, R2, R3, R4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.
    Type: Grant
    Filed: August 19, 1999
    Date of Patent: August 27, 2002
    Assignee: Pfizer Inc.
    Inventors: William Stephen Faraci, Willard McKowan Welch, Jr.
  • PYRAZOLES AND PYRAZOLOPYRIMIDINES HAVING CRF ANTAGONISTIC ACTIVITY
    Publication number: 20020016333
    Abstract: The pyrazoles and pyrazolopyrimidines of the formula 1
    Type: Application
    Filed: August 19, 1999
    Publication date: February 7, 2002
    Inventors: WILLIAM STEPHEN FARACI, WILLARD MCKOWAN WELCH
  • Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
    Patent number: 6103900
    Abstract: The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.
    Type: Grant
    Filed: October 30, 1997
    Date of Patent: August 15, 2000
    Assignee: Pfizer Inc
    Inventors: William Stephen Faraci, Willard McKowan Welch, Jr.
  • Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
    Patent number: 6005109
    Abstract: The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective In the treatment of a wide range of diseases including stress-related illnesses.
    Type: Grant
    Filed: October 30, 1997
    Date of Patent: December 21, 1999
    Assignee: Pflizer Inc.
    Inventors: William Stephen Faraci, Willard McKowan Welch, Jr.
  • Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
    Patent number: 5712303
    Abstract: The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.
    Type: Grant
    Filed: June 14, 1995
    Date of Patent: January 27, 1998
    Assignee: Pfizer Inc.
    Inventors: William Stephen Faraci, Willard McKowan Welch, Jr.